| Drug Name: | Metformin (657-24-9) |
|---|---|
| PubChem ID: | 4091 |
| SMILES: | CN(C)C(=N)N=C(N)N |
| InchiKey: | XZWYZXLIPXDOLR-UHFFFAOYSA-N |
| Therapeutic Category: | Hypoglycemic Agents |
| Molecular Weight (dalton) | : | 129.167 |
| LogP | : | -1.24383 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 91.49 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Prevention Of Dexamethasone-Induced Insulin Resistance | glucose transporters (P00019) | Metformin might influence the intrinsic activity of glucose transporters, as well as altering their intracellular translocation,which leads to Prevention of dexamethasone-induced insulin resistance [ ADR Type 2 ] | Prevention of dexamethasone-induced insulin resistance by metformin |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category